The presence of these receptors in OSCC patients correlated with low disease-free survival,201 and in patients with ovarian cancer high expression of TrkB correlated with low overall and disease-free survival.202 However, in neuroblastoma patients, high expression of TrkA or TrkC correlates with a better prognosis.203,204. This evidence concerns the gene NTRK2 and ovarian carcinoma.